Medical Education Research and Innovation Conference set for Dec. 8 – The South End

The Wayne State University School of Medicine will conduct its second annual Medical Education Research and Innovation Conference on Dec. 8 to showcase completed and in-progress medical education research and innovation projects conducted by students, residents, staff and faculty.

This years conference, to be held virtually from 2 to 6 p.m., will feature more than 100 posters and oral presentations. Dean Mark E. Schweitzer, M.D., will provide a welcome and opening remarks.

Featured speakers include Holly Gooding, M.D., associate professor of Pediatrics at the Emory University School of Medicine and co-director of the Harvard Macy Program for Educators in the Health Professions; and Anna Cianciolo, Ph.D., associate professor of Medical Education at the Southern Illinois University School of Medicine and editor in chief of Teaching and Learning in Medicine.

Projects that will be presented are entered into two categories:

Medical Education Research: Research related to the learning process that occurs within a medical education setting. Topics include, but are not limited to, learner characteristics, optimizing the learning process, assessment and evaluation, professional development, instruction design, technology in the learning environment and wellbeing. Medical education research can also include quality improvement projects.

Medical Education Innovation: Innovative curricula that address a current issue within medical education. The innovation is based on learning principles and designed to meet a specific need. Examples include, but are not limited to, health and wellness, quality improvement, patient safety, interprofessional education and service learning. This category can include works in progress, including research and innovation projects that are being developed or have yet to be completed.

To attend the conference and view the agenda, RSVP here.

More:

Medical Education Research and Innovation Conference set for Dec. 8 - The South End

2 Corning-area natives experience COVID-19 pandemic battle on the frontlines – Star-Gazette

Democratic presidential nominee Joe Biden Friday attacked the Trump administration's handling of the coronavirus pandemic. Eight months into the crisis, Biden said the president "still doesn't have a plan, " adding "he's quit on you." (Oct. 23) AP Domestic

In 2003, Peter Young and Daniel Freeman were classmates inwhat was thenthe new Alternative School for Math &Science in Corning.

The two men, now both 30, grew up only a few miles apart, one in Corning, the other in Big Flats. Eventually, theyboth became doctors.

And in the spring of 2020,their paths weretogether again in a shared mission, hundreds of miles apart.

When the COVID-19 pandemic struck an unsuspecting populace earlier this year, both men found themselveson the front lines of a harrowing life-and-death battle.

Young was a senior resident at Columbia University Medical Center in New York City when the deadly and mysterious virus unleashed its devastation.

Dr. Peter Young(Photo: Provided)

More than 800 miles to the south, Freeman was performing similar duties at Emory University Hospital in Atlanta.

Related: Corning Inc.paint additive can fight COVID-19 virus

Despite years of college, medical school and internships, neither man was quite prepared for the frightening and surreal scenes they were about to experience.

"I got called in on a Sunday to take over for a colleague who was sick with COVID-19," said Young, 30. "It felt apocalyptic. People looked like they were out of a Mad Max movie, wearing gear they brought from home. We realized (the virus) spread through our community like wildfire."

As part of his residency in Atlanta, Freeman spent timein various departments to give him a well-rounded hospital experience.

Dr. Daniel Freeman(Photo: Provided)

In February, he was doing labor and delivery of babies. A month later, he was in the children's emergency department, and when the COVID-19 pandemic took grip in mid- to late March, he was in the adult ER.

What Freeman remembers most about those early days is the virus was new and nobody really knew what to expect although they quickly found out.

"When it started, we knew very little," Freeman said. "You get used to identifying patterns. That's how you diagnose people. With COVID, we had no idea what it was going to look like or how to diagnose it. There was a great deal of uncertainty at the beginning.

"We realized early that COVID-19 can lead to blood clots and heart attacks. We were seeing a lot of them," he said. "I never felt overwhelmed. I do remember having a sense of dread that something really bad was going to happen."

For Young, the experience at times was overwhelming, in part due to the relentless flow of infected patients, and the fact that initially, so many of them died.

"The first patient who died was 37. He died quickly and horribly," Young said. "That was the moment it got really scary for me on a personal level.

"We were making life and death decisions. For me, the trauma of that will last for a while," he said. "I remember making decisions where people died. Living with that is going to be challenging. None of us were prepared for this. People were dying so fast we were looking for places to put bodies so we could bring more (patients) in."

Freeman and Young were always science-minded, and that, coupled with a desire to help other people, led them both into medicine.

Freeman, who graduated from Notre Dame High School in 2009, earned a bachelor's degree in biochemistry from Vassar College in Poughkeepsie in 2013, and his medical degree in 2019 from the University of Central Florida College of Medicine.

He then followed his wife to Atlanta, where she had a job lined up.

Corning native Dr. Peter Young shows off the personal protective gear he wore while dealing with COVID-19 patients in a New York City hospital.(Photo: Provided)

Young, graduated from Corning-Painted Post East High School in 2009, and also studied chemistry, along with creative writing, at Williams Collegein Williamstown, Massachusetts, graduating in 2013.

Related: Corning Gorilla Glass scientists create face shields for local hospitals

Young earned his doctorate from Columbia University's medical school in 2017. In June of this year, he completed his internal medicine residency training at Columbia.

Young and his wife have since relocated to Los Angeles, but his time in New York City earlier this year gave him an opportunity to experience both the pandemic and the blossoming social justice movement.

The early tidal waveof COVID-19 cases eventually eased, and both doctors have gotten on with their lives and careers.

Freeman is still practicing in Atlanta, and he and his wife areexpecting their first child in December.

Freeman said the experience will have a lasting effect on his outlook, both professionally and personally.

Related: Take a seat on your couch, the doctor will log in shortly: Health in the COVID age

"It has made me more comfortable handling critically ill patients. It's learning how to keep everyone calm and trying to organize everyone and work as a team," he said. "In terms of my own life, I still come home and undress outside the house, and put my clothes in the washer. I have a lot of anxiety about bringing that stuff home.

"My wife has been fantastic through this whole thing," Freeman said. "We're still dealing with something we don't really understand."

Young and his wife live in West Los Angeles, and Young recentlystarted a new fellowship at UCLA Medical Center.

It's a much different environment from the one Young experienced while working inemergency rooms during the early COVID-19 onslaught, but that experience had a profound impact on his calling as well.

"I learned the importance of being really up front with people about loved ones. They needed to hear that their loved one was dying," Young said. "End of life care is something I'm interested in. (The pandemic) definitely helped me realize how precious life and health is.

"It was a privilege to be there for my patients and the community," he said. "I wouldn't trade that for anything."

Follow Jeff Murray on Twitter @SGJeffMurray. To get unlimited access to the latest news, please subscribe or activate your digital account today.

Related: Coronavirus: Guthrie asks and receives, Dresser-Rand producing 3,000 face shields

Read or Share this story: https://www.stargazette.com/story/news/local/2020/11/30/2-doctors-corning-experience-covid-19-battle-frontlines/6220696002/

Read the original:

2 Corning-area natives experience COVID-19 pandemic battle on the frontlines - Star-Gazette

Three Yalies honored for their impact on and beyond Yale with 2020 Yale-Jefferson Awards | Yale Alumni – Yale News

The Yale-Jefferson Awards are presented annually, recognizing sustained public service that is individual, innovative, impactful, and inspiring. The recipients are three Yalies a Yale College student, a graduate or professional school student, and a member of the alumni body all of whom have demonstrated service that draws on the Yale community and benefits the world beyond Yale.

By those and all measures, the 2020 honorees are most deserving. They have made an impact for minorities in STEM, for those in need, and for those with special needs improving the lives of their communities and those within them.

Here are your 2020 Yale-Jefferson Award recipients: Robert Fernandez 20 PhD, Scott Morris 80 MDiv, and Megan Sardis 21.

Yale is honoring Fernandez for his dedication to transforming and building programs to improve the diversity of STEM education at Yale and beyond, helping to shape the minds of future scientists within the university undergraduate and graduate communities. A dedicated mentor, Fernandez serves as a coordinator for Yales Science, Technology, and Research Scholars program (known as STARS II), which is committed to supporting women, minorities, the economically underprivileged, and historically underrepresented students in the sciences, engineering, and math. He also co-founded Cientfico Latino, a STEM organization that works to bolster the pipeline of underrepresented students in higher education in the sciences.

Fernandez is a decorated scientist, having been named a 2014 Paul and Daisy Soros Fellow and as one of the 100 most inspiring Hispanic/Latinx scientists in America by Cell Mentor. He received his PhD from the Molecular Biophysics & Biochemistry Department at Yale and is currently a postdoctoral scientist at Columbia University.

When I came to Yale, I didnt know how to navigate undergrad to grad school, and I didnt know how different it was a lot of self-learning and asking questions on topics youre not familiar with. Also, pretty much at the time I was the only Latino on my track and one of three in the entire department, Fernandez said. Through that experience, I learned that grad school isnt something you do by yourself; its something you do as a community. It taught me that sometimes under-represented students are pretty isolated in higher education. So, I wanted to do something to help the community, to work with undergraduates and prepare them for the next step.

Yale is honoring Morris for his dedication and tireless efforts to provide healthcare for those in need. He is the founder and chief executive officer of Church Health in Memphis, Tennessee, which provides quality, affordable healthcare for working, uninsured people and their families. A board-certified family practice physician and an ordained United Methodist minister, Morris has revolutionized healthcare for the working poor in Memphis, recruiting doctors, nurses, dentists, and more to volunteer, all while securing a broad base of financial support from the faith community. Buoyed by those efforts, Church Health has grown to become the largest faith-based, privately funded health center in the nation, serving more than 75,000 patients and handling approximately 44,000 patient visits annually.

For his efforts and great work, Morris has been recognized by a number of major organizations,including the American Medical Association,which awarded him its Excellence in Medicine Award in 2008.

I started Church Health after going to Yale Divinity School and then going to medical school and doing a residency in family medicine, Morris said. I came to Memphis to start the work we did in 1987, so Ive never had a real job. But for 34 years, Church Health has existed in order to provide healthcare under the umbrella of the faith community to the people who work to make our lives comfortable. We take care of those people who wash our dishes, who cut our grass, who take care of our children, who will one day dig our graves. They dont complain, yet when they get sick, their options are very few.

Yale is honoring Sardis for her work providing innovative healthcare solutions for children with disabilities. A believer in the power of community to help vulnerable children reach their full potential, Sardis co-founded the nonprofit organization SNUGS National, which has developed free aquatic clinics for special needs children at eight locations across the U.S. That includes Yales Payne Whitney gymnasium, where the sessions are run by Yale student volunteers. To date, SNUGS National has served more than 150 families and has raised more than $15,000 in donations, and it has cultivated a 13-member board with teams in finance, communications, marketing, and development.

As a student of Global Affairs, Sardis is on pace to graduate in May 2021. She has a specific interest in health initiatives on the African continent and hopes to attend medical school and pursue a career in pediatric global health after her time at Yale.

When I got to Yale, I noticed that there werent any real programs for children with special needs, and no program for swim lessons for children with special needs, Sardis said. So, I talked to the swim coach and we worked together to get this program off the ground. We started off with six Autistic girls who we got connected with through the Yale Child Study Center. And since then its taken off. As of last year, we had 150 kids of all different sorts of intellectual and developmental disabilities come be part of our program. Its been really, really great. Every time I go there, I fall even more in love with it.

Follow this link:

Three Yalies honored for their impact on and beyond Yale with 2020 Yale-Jefferson Awards | Yale Alumni - Yale News

Medical Education Market Will Hit Big Revenues In Future | Zimmer Biomet Institute, Medical Training College, Harvard Medical School – Murphy’s Hockey…

Latest released the research study on Global Medical Education Market, offers a detailed overview of the factors influencing the global business scope. Medical Education Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Medical Education. The study covers emerging players data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Harvard Medical School (United States),Johns Hopkins School of Medicine (United States),Oxford University Medical School (United Kingdom),School of Clinical Medicine, University of Cambridge (United Kingdom),Stanford University School of Medicine (United States),TACT Academy for Clinical Training (India),Zimmer Biomet Institute (United States),Medical Training College (United States).

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/63846-global-medical-education-market-1

Definition:

Medical education promotes a commitment to learning about the science behind the teaching and learning in medicine. It has been firmly established field including cardiothoracic, neurology, orthopedic, pediatric, radiology etc. disciplines. The asymmetric growth in medical schools is likely fostered by an increased willingness of individuals to travel for their medical education. However, the brain drain of trained physicians from low income to high-income settings has been well-recognized, migration for undergraduate medical education is a growing trend. For example, in the United States, the number of applicants for medical schools were estimated to be 90,000 in the year 2017. Medical schools are striving to expand their capacity to provide more avenues for medical education to aspirants across the United States

Market Influencing Trends:

Rapid technological advances in the medical industry

Increasing gamification in medical education

Exponential increase in the number of medical schools and medical students and migration for medical education and training

Market Drivers:

Development of virtual labs

Increasing government initiatives in various emerging economies such as India, China and Others

Restraints

Lack of practical awareness in distance learning paired with high fees for classroom training

Opportunities

Positive economic growth and vast student base coupled with rising investments in healthcare across the world

Growing spending on online education by consumers and sizeable investments

The Global Medical Education Market segments and Market Data Break Down are illuminated below:

Study by Type (Cardiothoracic, Neurology, Orthopedic, Oral and Maxillofacial, Pediatric, Radiology, Laboratory, Other), Mode Type (On-campus, Distance, Online), Course Type (Certifications and Trainings, Graduate courses,, Post-graduate courses)

Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/63846-global-medical-education-market-1

Analyst at AMA have conducted special survey and have connected with opinion leaders and Industry experts from various region to minutely understand impact on growth as well as local reforms to fight the situation. A special chapter in the study presents Impact Analysis of COVID-19 on Global Medical Education Market along with tables and graphs related to various country and segments showcasing impact on growth trends.

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.Strategic Points Covered in Table of Content of Global Medical Education Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Medical Education market

Chapter 2: Exclusive Summary the basic information of the Medical Education Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Medical Education

Chapter 4: Presenting the Medical Education Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying market size by Type, End User and Region 2014-2019

Chapter 6: Evaluating the leading manufacturers of the Medical Education market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries (2020-2025).

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Medical Education Market is a valuable source of guidance for individuals and companies in decision framework.

Data Sources & Methodology

The primary sources involves the industry experts from the Global Medical Education Market including the management organizations, processing organizations, analytics service providers of the industrys value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Companys Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

Get More Information: https://www.advancemarketanalytics.com/reports/63846-global-medical-education-market-1

What benefits does AMA research study is going to provide?

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enables clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

Contact Us:

Craig Francis (PR & Marketing Manager)AMA Research & Media LLPUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]

Connect with us athttps://www.linkedin.com/company/advance-market-analyticshttps://www.facebook.com/AMA-Research-Media-LLP-344722399585916https://twitter.com/amareport

Read the original:

Medical Education Market Will Hit Big Revenues In Future | Zimmer Biomet Institute, Medical Training College, Harvard Medical School - Murphy's Hockey...

Immelman, Griebie have mutual admiration for each other – CSB/SJU

Annie Griebie and Aubrey Immelman have established a true mutual admiration.

So its hard to say who holds who in the higher regard.

Griebie, a College of Saint Benedict senior psychology major from Minnetonka, Minnesota, considers Immelman to be her mentor, someone who has encouraged and supported her research and made her a better student.

Immelman, an associate professor of psychology at CSB and Saint Johns University, considers Griebie to be one of the most talented students hes had the privilege of teaching in his nearly 30 years at CSB and SJU.

Griebie came to CSB as a chemistry major and switched to biology during her first year, but that changed during her sophomore year.

I took introductory psych with Dr. Immelman just by chance in the fall of my sophomore year (in 2018), Griebie said. She followed that up with Immelmans evolutionary psychology course during spring semester 2019 and personality psychology in the fall.

I quickly realized I loved psychology, that I had a real passion for this field, she said. So, I changed my major at the end of my sophomore year to psychology, and I began research with him that summer.

I think one of the advantages of schools like Saint Bens and Saint Johns is getting to take courses in different subjects, and find out if you have a passion for a field or a discipline. I really didnt know anything about (psychology) until I took those classes.

Her research the past two summers involved assisting Immelman, who directs the Unit for the Study of Personality in Politics. Established in 1999, it is a collaborative faculty-student research program in the psychology of politics at CSB and SJU and specializes in the psychological assessment of presidential candidates and world leaders.

Over the years, the unit has conducted psychological assessments of presidents (George W. Bush, Barack Obama and Donald Trump), presidential candidates (Al Gore, Mitt Romney, John McCain and Hillary Clinton) and President-elect Joe Biden, among others.

My first summer, my primary responsibility was to collect diagnostically relevant data for our profiles. We collected those from media reports and other sources, and used them to supplement the leader profiles we were working on, said Griebie, a graduate of Benilde-St. Margarets School.

It soon became evident that she had developed a sophisticated understanding of personality dynamics, so I increasingly relied on her to assist with the more complex coding and classification decisions involved in developing the personality profiles of presidential candidates, Immelman said.

This past summer, he (Immelman) gave me a lot more independence in the research and responsibility. He allowed me to advise the other two student researchers who worked with us this past summer, and he also trusted me to train a psychology student at St. Francis Xavier University in Nova Scotia, Canada, said Griebie, noting that collaboration produced an analysis of Canadian Prime Minister Justin Trudeau.

During that second summer, Annie continued with data collection but completed coding and classification tasks more or less independently, operating more as a colleague than as a research assistant, Immelman said, noting that Griebie assisted him in training an additional two graduate students at Lomonosov Moscow State University, Russias top-ranked university.

Griebie also co-authored a paper with Immelman on Trump, which was presented at the annual scientific meeting of the International Society of Political Psychology, and papers on Biden and Vice President-elect Kamala Harris.

The research process includes much deliberation among Immelmans team of student researchers. It truly is a team, Griebie said.

He has deliberately told me in the past that he sees us (students) as collaborators, and always urges me to express my own opinion, even when my opinion contradicts his own, Griebie said. Part of our research does involve that deliberation process, and within that process, he constantly encourages me to share my own thoughts on how I think the items should be categorized before even offering his own professional insights.

So, his encouragement and mentorship has really helped me to gain confidence in articulating my thoughts as well as help me feel like Im a valuable member of his research team, Griebie said.

Within that team setting, hes also helped me grow my own ability to do independent research as well, she said. Hes encouraged me to do an all-college thesis. Im working on elaborating the conceptual links between presidential leadership style and the personality-in-politics model that Dr. Immelman created and used in our research. So, hes really pushed me to become better as an independent researcher and student in general.

I do not believe in using students as mere data collectors doing the heavy lifting; I try to establish a collaborative, collegial relationship, Immelman said. Students play a significant role in helping me determine the personality profiles of the public figures under investigation by conducting targeted searches for specific life history and behavioral data I need for psychodiagnostic purposes.

Immelman is also helping Griebie take the next step toward post-baccalaureate studies, be it graduate programs in psychology or medical school.

No matter what program or school Ive told him Im thinking about, he always believes in it and believes in me, Griebie said. He is my adviser as well, and he has helped me take the right undergraduate classes as well as helped get a position as a teaching assistant and research experience, which is always super important when applying to the next step after Saint Bens.

I dont know if I would even consider applying to some of the programs that Im thinking about if he hadnt been so encouraging, Griebie added.

Immelman passed on his opening paragraph from Griebies medical school recommendation.

Among the scores of students for whom I have written recommendations for medical school or graduate programs in psychology, Anne Marie Griebie receives my strongest recommendation, easily ranking in the top 10%, he wrote.

In short, I consider Annie the best all-around, most talented student I have taught in my 30-year career; she possesses a rare combination of superior intellectual ability, high emotional intelligence, academic competence across the curriculum, genuine compassion, impeccable character and indefatigable conscientiousness, Immelman added.

Although Griebie says there are other professors at CSB and SJU who have helped mentor her, Immelman stands out.

Dr. Immelman has really, I believe, gone above and beyond. Hes been incredibly supportive. Hes given me such unparalleled opportunities and really fostered my entire education here, Griebie said.

Read more from the original source:

Immelman, Griebie have mutual admiration for each other - CSB/SJU

Lobe Sciences Announces Launch of Preclinical Study in Collaboration with the University of Miami Miller School of Medicine – Investing News Network

Lobe Sciences Ltd. is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine for the treatment of mild traumatic brain injuryconcussion with post-traumatic stress disorder . The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (Lobe or the Company) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (NAC) for the treatment of mild traumatic brain injuryconcussion (mTBI) with post-traumatic stress disorder (PTSD). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

The Miller School of Medicine is an internationally recognized leader in medical research, ranked No. 39 among the top medical schools in the nation by Blue Ridge Institute for Medical Research. In 2019, the medical school submitted 1,968 research proposals and was awarded $149 million in research funding from the National Institutes of Health (NIH).

Advances in neuro-diagnostic assessment have revealed mild traumatic brain injury (concussion) is more common than previously thought and potentially associated with a host of negative health outcomes. The Centers for Disease Control (CDC) estimates that there are 3 million emergency room visits and over 230,000 hospitalizations due to TBI in any given year in the United States alone. Also, at the same time there are 5.3 million Americans living with the effects of mTBI (a 53% increase over ten years ago). The World Health Organization calls traumatic brain injury a silent epidemic that affects over 70 million individuals across the world. The United States Department of Defense estimates that over 345,000 individuals are affected by mTBI and that 20% of all service members who deploy suffer mTBI. mTBI and PTSD are significant health care issues that often co-occur and impact each other.

Dr. Hoffer, the principal investigator on the study, said, This a very important extension of our work with NAC and other medicines to identify new treatments for mTBI and PTSD. We are hopeful that this new combination of psilocybin with NAC will lead us to better solutions for those suffering from mTBI and/or PTSD.

Maghsoud Dariani, Chief Science Officer of Lobe said, We are very excited to begin the preclinical studies in collaboration with Dr. Hoffer and his team at the University of Miami. They have made significant in-roads studying psychedelic medicine specifically as it relates to mTBI and PTSD. NAC has been shown as the only compound that has adequate pre-clinical studies to validate use and, to date, remains the only compound that has successfully completed a phase 1 equivalent trial in a population of individuals who had acute mTBI. Given there are currently no proven effective medical treatments for the treatment of mTBI and PTSD, we feel this is an important study that can lead to human clinical trials and eventually therapeutics to make a positive impact in the physical and mental wellbeing of millions of people.

About Lobe Sciences Ltd.

Lobe Sciences is a life sciences company focused on psychedelic medicines. Lobe conducts drug research and development using psychedelic compounds as well as development of innovative delivery mechanisms to improve mental health and wellness.

For further information please contact:

Lobe Sciences Ltd.Thomas Baird, CEOinfo@lobesciences.comTel: (949) 505-5623

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Disclaimer for Forward Looking Statements

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as will, may, should, anticipate, expects and similar expressions. All statements other than statements of historical fact included in this release, including statements regarding the future plans and objectives of the Company, the Companys expectations surrounding its development of treatments and/or therapeutics for mTBI and PTSD, goals and results of the preclinical research studies with the Miller School of Medicine and future expectations surrounding additional studies, research and development using NAC and psilocybin, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Companys expectations are risks detailed from time to time in the filings made by the Company with securities regulations. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including changes to the regulatory environment; and that the current Board and management may not be able to attain the Companys corporate goals and objectives. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/69106

Go here to see the original:

Lobe Sciences Announces Launch of Preclinical Study in Collaboration with the University of Miami Miller School of Medicine - Investing News Network

Physicians’ Role in Addressing Racism in-Training, the online peer-reviewed publication for medical students – Pager Publications, Inc.

Mercedes drove two hours to the nearest healthcare clinic to get her first physical exam in ten years. I met Mercedes while shadowing a primary care physician, Dr. L. In the clinic, Mercedes divulged to me how nervous she had been driving in she knew what the meeting held in store. Her fears were confirmed: just five minutes into her exam, Dr. L advised her, Mercedes, you have to lose weight.

Mercedes is part of a national epidemic. As of 2016, 40% of Americans are obese. When considering factors that impact an individuals weight, the public and the media tend to focus on individual behavior such as diet and exercise. We may blame individuals like Mercedes, attributing their weight to laziness. Try harder, Mercedes recounted to me in the clinic, is advice that she often hears.

However, this advice is inadequate. Though individual behavior plays a role, it cannot fully explain the striking disparity in the prevalence of obesity by race. Mercedes is a 46-year-old Black woman, and Black/African Americans disproportionately suffer from the highest obesity rates: 48% among Black/African Americans compared to 43% among Latinos, 35% among whites, and 12% among Asians. This disparity is especially concerning now since obesity increases the risk of severe illness from COVID-19.

The disproportionately high obesity rate among Black/African Americans stems from the broader issue of racism and its impact on the built environment, or the man-made aspects of where one lives.

Mercedes spent months searching for safe, affordable housing in Alabama before settling for her two-bedroom house next to Highway 18. Beginning in the 1930s, the US government refused to grant Black/African Americans housing loans in a policy called redlining, forcing Black/African Americans into poorer neighborhoods. Though redlining has long been banned, its impacts persist. Black/African Americans still form the majority of residents in redlined neighborhoods. Redlined neighborhoods generally lack access to fresh food, adequate green space, and bigger hospitals; they face more pollution and violence. With two jobs, a long commute, and two kids, the only downtime Mercedes gets is an hour in the late evenings. However, with few street lights and constant traffic in her neighborhood, she does not feel safe walking outside at night which has greatly limited her physical activity.

As a result of country-wide protests and increased awareness of the disproportionate burden of COVID-19 on racial and ethnic minority groups, more physicians are beginning to recognize the effects of race and racism on health. After Mercedes left the clinic that day, a quiet, low tone replaced Dr. Ls usually brassy voice as she talked through the situation with a colleague. Dr. L felt helpless as she treated Mercedes for high blood pressure and diabetes while knowing that Mercedes was going back to the same environmental conditions which were driving her ailments.

Some may wonder, is it a physicians duty to address racism? A physicians primary role is to provide the highest quality healthcare to those in need; however, racial biases can affect the delivery of care, especially in emergency situations. Racism undoubtedly has profound impacts on health, and physicians can address it in meaningful ways without overburdening themselves. In fact, addressing racism can improve medical care. It can help physicians identify a possible root cause of the health-harming conditions in which a patient may live and can reduce physicians implicit racial biases, which have also been shown to affect quality of care.

Learning how to integrate practices to reduce racial bias and inequity is a process that should start as early as medical school during hiring, admissions, and first-year training. During hiring and admissions, medical schools should aim for racial diversity among students, faculty, staff, and administration to help their affiliates meet people from different backgrounds, broaden their perspectives, and practice empathy.

Most medical schools have an orientation week intended to introduce first-year students to different aspects of the school and for students to get to one another and the faculty, staff, and administration. Medical schools, including Boston University School of Medicine, Harvard School of Medicine, and Johns Hopkins School of Medicine, integrate a racial equity workshop into that orientation week for students to learn about racial disparities in medicine, share stories about their experiences with race, and get comfortable talking about racism. Interventional studies show that these kinds of training and forums can help physicians better address racism by promoting effective dialogues on racism without requiring a significant time commitment.

First-year Clinical Skills courses can also incorporate training on long-term, structural issues like racism. While learning history-taking, for example, medical students should be trained to screen for social factors by asking patients questions such as, What do you do in your free time? Where do you shop for groceries? Do you feel safe in your neighborhood? These were the kinds of questions that had helped Dr. L better understand Mercedes lifestyle and environment and led Dr. L to identify racism as a possible risk factor for Mercedes health. These questions build trust and can open the door for further conversations about patient experiences with racism.

The recommendation for physicians to learn about and address racism in a clinical setting is just the beginning. A physicians role is to not only dig deeper into a patients history but also to connect patients with other individuals and organizations. This first step is to initiate communication with an interdisciplinary team, including dieticians, social workers, and organizations such as support groups.

Dieticians are the most obviously applicable to Mercedes case. However, an interdisciplinary team is necessary to tackle health problems that are related to systemic issues, such as racism. Social workers can help identify unsafe aspects of Mercedes environment and relay this information to state organizations to propel systemic change. Support groups can help Mercedes find community and provide safety in numbers. This multi-level cooperation can raise awareness about the effect of racism on health and mitigate racial disparities in social support and access to medical care.

On a larger scale, a physicians role is to employ patient narratives to help put a face to governmental issues. Mercedes case highlights several relevant issues: housing discrimination, universal healthcare, and federal funding for community health centers. Housing discrimination had forced Mercedes into health-harming conditions. Mercedes had postponed getting her physical and had to drive two hours that day because there was no other clinic nearby that accepted her insurance. Universal healthcare could have encouraged Mercedes to seek care earlier and more frequently. Similarly, increased funding for community health centers could help improve existing centers or open new centers in communities like Mercedes.

Student groups, such as American Medical Association/Medical Student Section (AMA/MMS), can give medical students a platform to learn about and express their opinions on these issues. AMA/MMS is the largest organization of medical students in the United States. Many medical schools have a student group that manages the AMA/MMS chapter at the school. AMA/MMS student and physician leaders teach newer medical students how to craft policy briefs. AMA/MMS also offers the opportunity to attend policy-making conferences and vote on state and national issues.

Student groups, such as AMA/MMS, can teach physicians to identify racist policies and to be advocates for their patients on a larger scale. Along with facts and statistics, physicians can share their personal experiences with having to send patients, such as Mercedes, back to health-harming conditions. On the frontlines of the obesity epidemic, physicians can counter those who blame the patients without acknowledging the broader factors at play. Addressing racism in this way can lead to hospital-, state- and national-level changes in progress towards health equity.

Image Credit: 02a.MTA.Bus.BaltimoreMD.9July2020(CC BY-SA 2.0)byElvert Barnes

Contributing Writer

Boston University School of Medicine

Swetha is a first-year medical student at Boston University School of Medicine in Boston, MA class of 2024. In 2020, she graduated from Boston University with a Bachelor of Arts in medical sciences. She enjoys singing, playing the ukulele, and baking in her free time.

Read the original post:

Physicians' Role in Addressing Racism in-Training, the online peer-reviewed publication for medical students - Pager Publications, Inc.

So You Traveled Over Thanksgiving. Now What? : Coronavirus Updates – NPR

A traveler waits for a flight at Portland International Airport in Oregon last week. Public health experts say it's important that people who traveled or gathered with others are especially careful over the next two weeks. Nathan Howard/Getty Images hide caption

A traveler waits for a flight at Portland International Airport in Oregon last week. Public health experts say it's important that people who traveled or gathered with others are especially careful over the next two weeks.

Despite the repeated warnings of public health experts and officials, millions of people traveled for Thanksgiving.

Perhaps you're one of them.

So what should you do now, to keep from creating the "surge upon a surge" of coronavirus cases that Dr. Anthony Fauci is warning the U.S. could soon face?

"You have to assume you were exposed and you became infected"

Dr. Deborah Birx, the coordinator of the White House's coronavirus task force, has this advice: Assume you picked up the virus.

"If your family traveled, you have to assume you were exposed and you became infected, and you really need to get tested in the next week, and you need to avoid anyone in your family with comorbidities or are over 65," she told CBS' Face the Nation on Sunday.

She recommends masking indoors if people in your household traveled or gathered with others for Thanksgiving. "If you're young and you gathered," Birx says, "you need to assume that you're infected and not go near your grandparents and aunts and others without a mask."

If you're over 65 or have comorbidities and you gathered at Thanksgiving, watch out for symptoms.

"If you develop any symptoms, you need be tested immediately because we know that our therapeutics work best both our antivirals and our monoclonal antibodies work best very early in disease," Birx says.

Adm. Brett Giroir, a physician who oversees the federal government's testing response, says you need to be extra-careful as you return home though he says you don't necessarily need to do a strict two-week quarantine.

"Just remember you've had an increased risk of being exposed," he told CNN. "So you should decrease unnecessary activities for about a week. And if you can get tested in three or five days, that's also a very good idea."

This is the time to be extra-careful and wear masks and avoid crowds, because of the increased risk that you might have gotten the coronavirus and you could spread it.

"There certainly can be a surge because of the travel and the mixing of people who have not been in their own little pods," he said, calling this "a risky time."

What happens next depends on the precautions that people take now, Giroir said.

"We're very concerned about the travel, but what we do makes a difference. It's not as if we're passive onlookers," he said. "We could really make a difference here."

Birx agrees: "What happened happened. I mean, we know that people got together in Thanksgiving. The moment now is to protect those from having secondary and tertiary transmissions within the family."

What do other experts say?

Abraar Karan is an internal medicine doctor at the Brigham and Women's Hospital and Harvard Medical School.

His advice is that those returning from travel but who don't have a known COVID-19 exposure should quarantine for the next 7-10 days. If they have a known exposure, they should quarantine for two weeks.

Why does he recommend a quarantine for all who traveled? Because of the high levels of viral transmission around the U.S. right now including by people who are asymptomatic.

"[P]eople will be exposed to others who are infectious but not showing any symptoms. So in many cases, they won't even know that they had an exposure," he wrote by email to NPR. "Many people are saying they have no idea where they were infected."

He recommends getting tested twice: ideally when you first return home, and then again 3-5 days later.

"This will notably increase the chance that you detect the virus over a longer incubation period," he says.

And Karan emphasizes that it's important to do the quarantine right. "Quarantining doesn't mean walking around your house or apartment as if you're healthy. It means staying in your room and avoiding contact with other people as if you were infected. It means wearing a mask when you leave your room if you need to do that."

Keep in mind that different states have different rules for returning travelers so check to see what is required where you live. The requirements may depend on where you traveled.

When will we know how much the virus spread over Thanksgiving?

The incubation period for the virus is 2 to 14 days, and people who get the virus generally develop symptoms 5-6 days after exposure.

"If there was a lot of spread around Thanksgiving, we'll be seeing that around a week or two or three into December, and onward," former CDC Director Dr. Tom Frieden told NPR's Allison Aubrey.

"Unfortunately, we have far too much spread in the United States, and because of that, December is likely to be a hard month," Frieden warns.

And if you do test positive for the virus?

Be sure to share that information with the others you spent time with over the holiday weekend. If you want to protect your loved ones, they need to know they might have been exposed.

Read more:

So You Traveled Over Thanksgiving. Now What? : Coronavirus Updates - NPR

Safely celebrating the holidays during a pandemic – KHOU.com

Everything this past year has looked different thanks to COVID-19. The holiday season will be no exception.

Unfortunately, COVID-19 will still have a presence, and we will need to be vigilant during the most festive time of the year, said Karen Vigil, MD, associate professor of infectious disease at McGovern Medical School at UTHealth. I would strongly encourage families to think about alternative plans for this year as we continue to deal with the pandemic.

Celebrate safely

There are several low-risk activities you can participate in and still celebrate the season. The Centers for Disease Control and Prevention (CDC) deems the following activities as safe ways to help minimize the spread of the virus:

Get-togethers are not recommended

If you cant avoid a gathering with people outside of your household, its recommended that all participants strictly avoid contact with people outside of their household for 14 days prior to the gathering. Before deciding to do so, you also need to consider the rate of infection in your particular community.

Should you decide to move forward, outdoor events are safer than ones held inside because of ventilation and airflow. You should also shorten the length of your gathering, limit the number of people in attendance, consider where participants are coming from, and evaluate their behavior. If participants are not wearing masks or practicing social distancing, they pose a risk to others in attendance.

Stop the spread

If you or anyone you live with is under the weather, you should not plan to host an event or attend an in-person gathering.

If you or someone in your household has symptoms of COVID-19, you should forgo in-person plans and participate in celebrations virtually, said Vigil. Your friends and loved ones will understand and will thank you later for putting your health (and theirs) first.

If you have been diagnosed with COVID-19, are waiting for results, or at increased risk of severe illness, you should plan on staying home.

Home for the holidays

The CDC says that traveling increases the chance of getting and spreading COVID-19. Staying home is the best way to protect yourself and others. Consider setting aside some time for video chats to catch up with family and friends.

This years holiday season will be tough on many because of all these restrictions. We will miss our family and friends, and many of our traditions, said Vigil. But we must remain cautious and keep our guards up to save lives as we continue to deal with this pandemic.

Visit the CDC for more guidance on holiday celebrations. For more resources on the coronavirus, visit our information center.

As the clinical practice of McGovern Medical School at UTHealth, UT Physicians has locations across the Greater Houston area to serve the community. To schedule an appointment, call 888-4UT-DOCS. For media inquiries, please call 713-500-3030.

Continued here:

Safely celebrating the holidays during a pandemic - KHOU.com

2020 AAAS Fellows approved by the AAAS Council – Science Magazine

In October 2020, the Council of the American Association for the Advancement of Science elected 489 members as Fellows of AAAS. These individuals will be recognized for their contributions to science and technology during the 2021 AAAS Annual Meeting. Presented by section affiliation, they are:

Ann M. Bartuska, Resources for the Future

Carl Bernacchi, U.S. Department of Agriculture Agricultural Research Service

Amy O. Charkowski, Colorado State Univ.

Clarice J. Coyne, U.S. Department of Agriculture Agricultural Research Service

Geoffrey E. Dahl, Univ. of Florida

Roch E. Gaussoin, Univ. of Nebraska-Lincoln

Patrick M. Hayes, Oregon State Univ.

Thomas J. (TJ) Higgins, CSIRO Agriculture and Food (Australia)

Nancy Collins Johnson, Northern Arizona Univ.

Shibu Jose, Univ. of Missouri

Daniel Kliebenstein, Univ. of California, Davis

Rosemary Loria, Univ. of Florida

Shailaja K. Mani, Baylor College of Medicine

Rafael Muoz-Carpena, Univ. of Florida

David D. Myrold, Oregon State Univ.

K. Raja Reddy, Mississippi State Univ.

Jean Ristaino, North Carolina State Univ.

Jeanne Romero-Severson, Univ. of Notre Dame

Pablo Juan Ross, Univ. of California, Davis

Jennifer L. Tank, Univ. of Notre Dame

William F. Tracy, Univ. of Wisconsin-Madison

Margaret W. Conkey, Univ. of California, Berkeley

Anne Grauer, Loyola Univ. Chicago

Debbie Guatelli-Steinberg, The Ohio State Univ.

Edward B. Liebow, American Anthropological Association

J. Terrence McCabe, Univ. of Colorado Boulder

Denise Fay-Shen Su, Cleveland Museum of Natural History

Nancy Susan Brickhouse, Harvard-Smithsonian Center for Astrophysics

John E. Carlstrom, Univ. of Chicago

Sean Carroll, California Institute of Technology

Timothy Heckman, Johns Hopkins Univ.

Paul Martini, The Ohio State Univ.

Norman Murray, Canadian Institute for Theoretical Astrophysics

Joan R. Najita, National Science Foundation's NOIRLab

Liese van Zee, Indiana Univ.

Risa Wechsler, Stanford Univ.

Ellen G. Zweibel, Univ. of Wisconsin-Madison

Ghassem R. Asrar, Universities Space Research Association

Elizabeth Boyer, Pennsylvania State

Deborah Bronk, Bigelow Laboratory for Ocean Sciences

Rong Fu, Univ. of California, Los Angeles

Isaac Held, Princeton Univ. Atmospheric and Oceanic Sciences Program

Forrest M. Hoffman, Oak Ridge National Laboratory

William K. M. Lau, Univ. of Maryland

Zhengyu Liu, The Ohio State Univ.

Natalie Mahowald, Cornell Univ.

Sally McFarlane, U.S. Department of Energy

Jerry Schubel, Aquarium of the Pacific (Retired)

Patricia L. Wiberg, Univ. of Virginia

Mary Catherine Aime, Purdue Univ.

Suresh K. Alahari, Louisiana State Univ. Health Sciences Center School of Medicine

Gladys Alexandre, Univ. of Tennessee, Knoxville

Craig Reece Allen, Univ. of Nebraska-Lincoln

Sonia M. Altizer, Univ. of Georgia

Swathi Arur, The Univ. of Texas MD Anderson Cancer Center

Alison M. Bell, Univ. of Illinois at Urbana-Champaign

Elizabeth T. Borer, Univ. of Minnesota

Lisa Brooks, National Human Genome Research Institute

John Michael Burke, Univ. of Georgia

George A. Calin, The Univ. of Texas MD Anderson Cancer Center

Andrew G. Campbell, Brown Univ.

Alice Y. Cheung, Univ. of Massachusetts Amherst

Anita S. Chong, Univ. of Chicago

Gregory P. Copenhaver, Univ. of North Carolina at Chapel Hill

Leah E. Cowen, Univ. of Toronto (Canada)

Dana Crawford, Case Western Reserve Univ.

Charles F. Delwiche, Univ. of Maryland, College Park

Diana M. Downs, Univ. of Georgia

Jeffrey Dukes, Purdue Univ.

Peter Dunn, Univ. of Wisconsin-Milwaukee

Jonathan Eisen, Univ. of California, Davis

Eva Engvall, Sanford Burnham Prebys Medical Discovery Institute

Valerie Eviner, Univ. of California, Davis

Philip Martin Fearnside, INPA - National Institute of Amazonian Research (Brazil)

Gloria Cruz Ferreira, Univ. of South Florida

J. Patrick Fitch, Los Alamos National Laboratory

John W. Fitzpatrick, Cornell Univ.

Christopher Francklyn, Univ. of Vermont

Serita Frey, Univ. of New Hampshire

Andrea L. Graham, Princeton Univ.

Michael William Gray, Dalhousie Univ. (Canada)

Karen Jeanne Guillemin, Univ. of Oregon

Paul Hardin, Texas A&M Univ.

Stacey Lynn Harmer, Univ. of California, Davis

Jessica Hellmann, Univ. of Minnesota

Nancy Marie Hollingsworth, Stony Brook Univ.

Charles Hong, Univ. of Maryland School of Medicine

Laura Foster Huenneke, Northern Arizona Univ.

Mark O. Huising, Univ. of California, Davis

Travis Huxman, Univ. of California, Irvine

Kenneth D. Irvine, Rutgers, The State Univ. of New Jersey

Ursula Jakob, Univ. of Michigan

Janet K. Jansson, Pacific Northwest National Laboratory

Susan Kaech, Salk Institute for Biological Studies

Patricia Kiley, Univ. of Wisconsin-Madison

Joan Kobori, Agouron Institute

Barbara N. Kunkel, Washington Univ. in St. Louis

Armand Michael Kuris, Univ. of California, Santa Barbara

Pui-Yan Kwok, Univ. of California, San Francisco

Read the original post:

2020 AAAS Fellows approved by the AAAS Council - Science Magazine

Students Share Medical School Details You Won’t Find Anywhere Else | University of Michigan – Michigan Medicine

Applying to medical school is an extremely stressful experience, and Michigan medical students know that firsthand. Thats why five students took time to share their insights with hundreds of prospective students during a recent video livestream Q&A.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Topics ranged from curriculum and mentorship to application advice and much more. Below, read through a few highlights from the session or watch the full video above to get all the topics covered.

One thing I wish I knew was that all I needed to do to get into medical school was to be myself and not try to be anything other than that.

I think when you're preparing for a process where everything that you've done and who you are is going to be heavily judged, you try to be the best version of yourself, and sometimes that's not the most honest or truthful version of yourself. Now, being on the other side of this, I've realized that they don't want that perfect applicant. They really just want you. So I wish I knew that prior to applying. It would have saved me a lot of stress and trouble in the process.

I've been very pleasantly surprised by how much of a work-life balance I feel I have. Everyone was telling me, Med school is hard, you're not going to have a life, all you're going to do is study, which is sort of true. But on the other hand, I feel like I really do have time to go have dinner with friends during the week or go Up North for a weekend. The pass-fail curriculum is really important and really crucial to allow work-life balance, and I've really tried to embrace that.

For me it was about seeing that everyone was really enthusiastic about their place in medicine, but also just enthusiastic human beings in general. It's really nice to be in an environment where everyone else is as high energy as you are. That's what I felt on my interview day and pretty consistently throughout my first year and now in this Transition to Clerkship period. Everybody that I've worked with here just has that energy and passion and drive that is medically related, but they also just have that human, fun, personal life-related energy and passion as well, which was really important for me.

SEE ALSO: DOCUMENTARY - Reality Checks: Michigan Medical School Students Open Up

My partner moved to Michigan with me and started a master's program. Something I've really appreciated is, for students with significant others or families locally, there are a lot of activities relating to the med school where you can bring your people. That's been really helpful for me in trying to integrate those parts of my life. So, for many things, you can come alone or come be a part of those activities with your significant other so they can join that broader group.

After taking the Step 1 exam, you return early in your third year and do two month-long sequences of transitioning to Branches. You have to do an intensive care unit rotation, an emergency medicine rotation and a sub-internship rotation in a field that you're interested in. But there's a lot of flexibility. You can choose quite a few electives and even create your own. This past year one of my friends created an elective in veterinary medicine and had a fun time exploring that. You can really branch out in your interests and work closely with faculty members. And there's a good amount of time to do research or to do a dual degree.

Like Podcasts? Add the Michigan Medicine News Breakto your Alexa-enabled device orsubscribe for updates oniTunes,Google PlayandStitcher.

Search #GoBlueMed on Twitter to see more Michigan med students answers to a range of questions.

Go here to read the rest:

Students Share Medical School Details You Won't Find Anywhere Else | University of Michigan - Michigan Medicine

5 ways the pandemic may transform medical education – American Medical Association

As the response to the COVID-19 pandemic restricted in-person activity, medical schools had to invent new ways to educate out of necessity. Some of those innovative methods may have staying power that go well beyond the pandemic, reshaping how tomorrows doctors are trained.

When you face a disruption on the order of this magnitude, it forces you to think about the principles by which we preserve the very essence of our work. We quickly learn that some strategies we assumed were the only way to do things can be changed without damaging the quality of our educational programs, said Catherine Lucey, MD. She is vice dean for education at the University of California, San Francisco, School of Medicine, one of the 37 member schools ofAMAs Accelerating Change in Medical Education Consortium.

A lot of changes were put in place to deal with COVID-19 disruption, but its also given us a new freedom to experiment with new models of education that may end up being better, Dr. Lucey said in an interview with the AMA.

Dr. Lucey and co-author S. Claiborne Johnston, MD, PhD, highlighted five potential COVID-19-related changes to medical education that may have staying power in a JAMA Viewpoint essay, The Transformational Effects of COVID-19 on Medical Education.

In response to the COVID-19 pandemic, medical schools have created electives giving medical students the chance to engage with the public health response. Learners also served as evidence-based ambassadors for the population at large.

The pandemic strengthened the partnership between health care delivery systems and public health professionals, Dr. Lucey said. The outbreak of the COVID-19 pandemic was acute and dramatic, but it made people reset their idea of what it means to alleviate suffering in our patients and improve the health of our communities.

Its not just doctors operating alone, and its not just a cardiologist and a basic science investigator working alone, she added. It requires everyonethat means doctors, nurses, public health experts, policy experts, all of those people are required to solve problems.

Dr. Lucey added that this type of approach could be applied to other public health crises such as the opioid epidemic and the ongoing pandemic of health care disparities.

Find out how medical schools innovated to engage medical students during the pandemic.

The pandemics onset was a teachable moment for any health professional. In her JAMA Viewpoint essay, Dr. Lucey outlined what that meant for medical students and how it could be adapted going forward.

The pandemic helped cement the shift to a philosophy of really focusing on the role of the physician in reasoning through ambiguous and unknown problems as the focus of education, rather than teaching students that the role of physician was to memorize a body of knowledge that was already in existence and good enough for what usually happens, Dr. Lucey said. Thats a really important philosophic difference. The first approach really creates physician problem-solvers who are capable of addressing both enduring and emerging threats to health.

Learn how med schools used 3 learning models to keep students on track during COVID-19.

When the physician workforce proved to be overwhelmed in certain hot spots, states called on medical schools to graduate their fourth-year students months early to help bolster the response. The measures required navigating somewhat cumbersome red tape but demonstrated that move could be an option in the future.

The pandemic showed us an example of why we need to think about early graduation for our students, and it showed us all the hurdles we will need to jump over to do it, Dr. Lucey said. Its a shock to the system that asks the question: if we are willing to attest that our students are competent to graduate early in the pandemic, could we not also do so as a matter of usual practice?

Find out how a med school in a COVID-19 hot spot deployed early graduates.

The pandemic caused the cancellation of most away or visiting rotations. That could create a more level playing field going forward, since not all students can access such experiences.

The opportunity to go around the country and do audition rotations is a clear legacy practice, Dr. Lucey said. When you talk with people about it, its not clear who it benefits the most. Does it benefit the students or the programs?

In spite of the absence of away rotations, I dont believe that programs will see a big difference in the quality of that they recruit and match into their programs, Dr. Lucey said. As such, it is possible that we will be rethinking whether these rotations should be restarted next season.

Get four expert tips on how 2021 residency applicants can succeed with video interviews.

Medical schools were proactive in communicating expectations and restrictions with students. Going forward, Dr. Lucey envisions a more dedicated approach to student outreach during turbulence. She pointed to the civil unrest surrounding police brutality that took place on the heels of the pandemic as a potential example of a time in which that new approach had paid off in medical education.

It created another really existential disruption to the way many of our learners were approaching their education, Lucey said. Our faculty of color and students of color, and the allies that work with them, were really shaken to the bone by this vivid reminder of the elements of structural racism that exist within our communities. In situations like this, leaders of educational programs need to be facile with crisis communication strategies that support all stakeholders during these crises.

Consider how to support diverse learners during disruption.

The AMA has curateda selection of resourcesto assist residents, medical students and faculty during the COVID-19 pandemic to help manage the shifting timelines, cancellations and adjustments to testing, rotations and other events at this time.

Link:

5 ways the pandemic may transform medical education - American Medical Association

Trump doctor Conley degree from Philadelphia College of Osteopathic Medicine: What it means – On top of Philly news – Billy Penn

Love Philly? Sign up for the free Billy Penn email newsletter to get everything you need to know about Philadelphia, every day.

The doctor whos been treating President Donald Trump for the coronavirus has roots in Philadelphia. Its where he trained in medicine.

Dr. Sean Conley, the 40-year-old whos been at the forefront of national health updates lately, has been the presidents physician for two years. He grew up in Doylestown, and graduated from Central Bucks High School East in 1998. His medical degree comes from the Philadelphia College of Osteopathic Medicine.

The Philly higher ed institution is not your average medical school. Turns out Conley doesnt actually have an MD degree.

Instead, hes a DO a doctor of osteopathic medicine. With that certification, Conley can do everything a regular doctor can do, like prescribe medicine and perform surgery in all 50 states.

The training is different in that it takes a more holistic look at the body than traditional medicine. It emphasizes primary care, and practices that encourage the body to heal itself rather than the immediate prescription of medicine or use of surgery to correct problems.

At first, the practice was highly controversial. During the first decade of PCOMs existence, it wasnt even legal in Pennsylvania. Over the next two centuries, debates over osteopathy continued, with traditional physicians critiquing its more controversial practices like the in the late 1800s idea to shake a child to cure scarlet fever.

In recent years, the stigma has mostly dissolved as the training and practice have themselves become more legit. Now, earning a DO degree requires the same training as an MD, plus extra coursework.

Conleys Philly alma mater is considered a pioneer in the field, and helped see it through to the modern day.

The first person to bring osteopathic medicine to Philadelphia was a woman named Clara Martin. In 1899, the city directory listed her as an osteopath, working from an office on 67th Street near the Cobbs Creek Parkway, just south of Mount Moriah Cemetery.

That same year, two physicians named Snyder and Pressly founded what would become PCOM, then called the Philadelphia College and Infirmary of Osteopathy.

Philly was experiencing a general boom in medical institutions right then, notes a published history of the school called To Secure Merit, by Carol Benenson Perloff. Episcopal Hospital, German Hospital (now Lankenau), Jewish Hospital (now Einstein Medical Center) and Presbyterian Hospital were all founded between 1849 and 1882.

PCOM first opened at 12th and Market, filling two rooms inside a 13-story office tower. Within a year, it outgrew that space and relocated to the Witherspoon building at Juniper and Walnut.

Enrollment kept growing. Many students were people inspired by seeing osteopathic doctors step in after traditional medicine had failed.

Alum Arthur Flack, who graduated in 1906, said he got interested when he saw osteopathic medicine helped cure cases of typhoid fever amid an epidemic in his hometown of Butler, Pa.

When I first became a studentmy marvel was as to the intense devotion manifested by the small group of physicians headed by you, Flack said in 1925, according to Perloffs book. Without such sincere devotion, Osteopathy today would be only a memory in Pennsylvania.

Thing is, osteopathy wasnt even legally recognized when PCOM first opened its doors.

The first attempt to legalize it in Pennsylvania passed through the state legislature in 1905, but was vetoed by then-Governor Pennypacker. It wasnt until 1909 that a Governor Stuart signed the bill to allow osteopathic doctors to apply for state licensure, 10 years after the Philadelphia college was first founded.

Licensing made the practice more popular, and PCOM continued to outgrow its facilities. The school moved to Spring Garden Street, then to 33rd and Arch, and eventually to North Broad Street.

Some drama: Before the legalization of osteopathy, the college had raised about $3,000. But the founders continued not to pay faculty with actual money for their teaching they compensated them only with stock in the school.

In 1904, faculty started demanding payment. The founders refused, and there was a theatrical back-and-forth in which the schools deans threatened to resign unless the two founders resigned. Shockingly, both founders did resign, and a board of trustees was established that still exists today.

By 1910, PCOM was considered a pioneer when it became one of the first to adapt to new statewide legalization requirements, and create a four-year program, which it maintains to this day.

After those gazillion relocations and expansions, PCOM landed at its current campus on City Avenue at the Bala Cynwyd border.

The school currently has almost 2,000 students, across areas of study like clinical psychology, biomedical sciences and forensic medicine. Like osteopathic medicine schools nationwide, its really tough to get in. In 2019, nearly 7k students applied for just 441 spots in the program.

Dr. Conley, Trumps doctor, has a degree that takes four years to complete. The first two are spent learning basic and clinical sciences, and the second two doing hands-on work in teaching hospitals.

While enrolled, the Bucks County native likely got plenty of Philly experience, since students spend four months working in city neighborhoods at PCOMs Community Healthcare Centers.

After their four years, some students declare a specialty and spend more time in school. PCOM reports that a majority of its grads end up in family medicine, general internal medicine, OB/GYN or pediatrics.

In general, osteopathic medicine has grown in popularity in recent years seen as a more hands-on version of health care. DOs work to understand how all parts of the body are connected, and take a major focus on preventative and primary care.

An osteopathic medicine student in New York told the New York Times in 2014 she became interested in the practice after a standard MD said shed need surgery to correct her chronic ear infections but then she went to a DO, who corrected the problem by stretching her neck, she said.

The infection happened because of fluid in the ear, said the student, Gabrielle Rozenberg, and the manipulations opened up the ear canal.

The practice has become widespread enough that PCOM has opened two more campuses, both in Georgia. According to the American Association of Colleges of Osteopathic Medicine, about 25% of all medical students today are training at an osteopathic school.

See more here:

Trump doctor Conley degree from Philadelphia College of Osteopathic Medicine: What it means - On top of Philly news - Billy Penn

In a First, New England Journal of Medicine Joins Never-Trumpers – The New York Times

Throughout its 208-year history, The New England Journal of Medicine has remained staunchly nonpartisan. The worlds most prestigious medical journal has never supported or condemned a political candidate.

Until now.

In an editorial signed by 34 editors who are United States citizens (one editor is not) and published on Wednesday, the journal said the Trump administration had responded so poorly to the coronavirus pandemic that they have taken a crisis and turned it into a tragedy.

The journal did not explicitly endorse Joseph R. Biden Jr., the Democratic nominee, but that was the only possible inference, other scientists noted.

The editor in chief, Dr. Eric Rubin, said the scathing editorial was one of only four in the journals history that were signed by all of the editors. The N.E.J.M.s editors join those of another influential journal, Scientific American, who last month endorsed Mr. Biden, the former vice president.

The political leadership has failed Americans in many ways that contrast vividly with responses from leaders in other countries, the N.E.J.M. said.

In the United States, the journal said, there was too little testing for the virus, especially early on. There was too little protective equipment, and a lack of national leadership on important measures like mask wearing, social distancing, quarantine and isolation.

There were attempts to politicize and undermine the Food and Drug Administration, the National Institutes of Health and the Centers for Disease Control and Prevention, the journal noted.

As a result, the United States has had tens of thousands of excess deaths those caused both directly and indirectly by the pandemic as well as immense economic pain and an increase in social inequality as the virus hit disadvantaged communities hardest.

The editorial castigated the Trump administrations rejection of science, writing, Instead of relying on expertise, the administration has turned to uninformed opinion leaders and charlatans who obscure the truth and facilitate the promulgation of outright lies.

The uncharacteristically pungent editorial called for change: When it comes to the response to the largest public health crisis of our time, our current political leaders have demonstrated that they are dangerously incompetent. We should not abet them and enable the deaths of thousands more Americans by allowing them to keep their jobs.

Scientific American, too, had never before endorsed a political candidate. The pandemic would strain any nation and system, but Trumps rejection of evidence and public health measures have been catastrophic, the journals editors said.

The N.E.J.M., like all medical journals these days, is deluged with papers on the coronavirus and the illness it causes, Covid-19. Editors have struggled to reconcile efforts to insist on quality with a constant barrage of misinformation and misleading statements from the administration, said Dr. Clifford Rosen, associate editor of the journal and an endocrinologist at Tufts University in Medford, Mass.

Our mission is to promote the best science and also to educate, Dr. Rosen said. We were seeing anti-science and poor leadership.

Mounting public health failures and misinformation had eventually taken a toll, said Dr. Rubin, the editor in chief of The New England Journal of Medicine.

It should be clear that we are not a political organization, he said. But pretty much every week in our editorial meeting there would be some new outrage.

How can you not speak out at a time like this? he added.

Dr. Thomas H. Lee, a professor of medicine at Harvard Medical School and a member of the journals editorial board, did not participate in writing or voting on the editorial.

But to say nothing definitive at this point in history would be a cause for shame, he said.

Medical specialists not associated with the N.E.J.M. applauded the decision.

Wow, said Dr. Matthew K. Wynia, an infectious disease specialist and director of the Center for Bioethics and Humanities at the University of Colorado. He noted that the editorial did not explicitly mention Mr. Biden, but said it was clearly an obvious call to replace the president.

There is a risk that such a departure could taint the N.E.J.M.s reputation for impartiality. While other medical journals, including JAMA, the Lancet and The British Medical Journal, have taken political positions, the N.E.J.M. has dealt with political issues in a measured way, as it did in a forum published in October 2000 in which Al Gore and George W. Bush answered questions on health care.

But it is hard to imagine such a deliberative debate in todays acrimonious atmosphere, said Dr. Jeremy Greene, a professor of medicine and historian of medicine at Johns Hopkins University.

The Trump administration, he said, had demonstrated a continuous, reckless disregard of truth.

If we want a forum based on matters of fact, it strikes me that no form of engagement could work, Dr. Greene added.

Read this article:

In a First, New England Journal of Medicine Joins Never-Trumpers - The New York Times

Brown University Medical School Dean to Lead Second Session of Five-Part Virtual Future of Medicine Summit : SF STAT! – South Florida Hospital News

October 5 2020 - Allan R Tunkel, Senior Associate Dean for Medical Education and Chief of Medical Education at the Brown University Alpert Medical School, will be presenting, The Impact of COVID-19 on Medical Education on Thursday, October 8, 6-7:30 p.m.nPresented by the Palm Beach County Medical Society (PBCMS) as part of the annual Future of Medicine Summit, the event is free to participants, who may register at:

Started in 2007 by Jose Arrascue, MD, the Future of Medicine Initiative brings together community leaders to define issues, establish partnerships and implement strategies for change. At the annual Summit, national and community health care leaders gather to explore the "hot topic" issues facing healthcare.

He received a Ph.D in experimental pathology before earning a medical degree at the College of Medicine and Dentistry of New Jersey in Newark. He completed a Residency in internal medicine at the Hospital of the Medical College of Pennsylvania in Philadelphia and an Fellowship in infectious diseases from the University of Virginia Health Sciences Center in Charlottesville. He has been at Brown since 2013 and previously taught at the Drexel University College of Medicine for a decade.

For more information and the Future of Medicine, Contact Katherine Zuber at KatherineZ@pbcms.org or 561-433-3940.

Originally posted here:

Brown University Medical School Dean to Lead Second Session of Five-Part Virtual Future of Medicine Summit : SF STAT! - South Florida Hospital News

Human brain dissected live in front of medical school students – The Argus

A MEDICAL school has become the first in the UK to live-stream a human dissection as part of a new virtual teaching technique.

Year two and medical neuroscience students at Brighton and Sussex Medical School (BSMS) witnessed a brain being removed.

They also had an introduction session where they explored the muscles and bones of the chest.

Social distancing restrictions as a result of the pandemic have forced universities online, blending curriculum with a mix of face-to-face and virtual teaching.

Staff at BSMS have implemented a blended medical curriculum to ensure students still receive face-to-face teaching in key clinical area and also benefit from digital innovations to support their learning.

One of these innovations has been to bring the dissecting room, a highly regulated space, to students via streaming.

The procedure had been carefully planned, considering the Human Tissue Authority regulations, and only involved donors who had consented to the activity.

Professor Claire Smith, head of anatomy, said: In responding to the current restrictions, it remains imperative that medical and surgical teaching continues.

In anatomy teaching, Covid-related restrictions have been compounded by the medical school only receiving half the number of donated cadavers for teaching. We are so fortunate to have donors and my thoughts are always with those who have suffered loss at such a difficult time.

This new innovation has meant the donors wish to educate and inform future generations can still occur, albeit in a slightly different way.

It is not only medical students who are benefiting.

Last month, a week-long course was arranged by Dr Jag Dhanda, using the live stream to demonstrate surgical procedures on cadavers with virtual reality (VR).

Multiple camera angle perspectives in the virtual reality view were live-streamed to 350 surgeons from 26 countries around the world.

Surgeons were able to view the surgical techniques on cadavers through virtual reality headsets that allowed them to choose the camera angle perspective they wanted by moving their heads.

One student who attended the brain dissection said they gained a lot from the experience.

He said: Its definitely a learning curve with all the new tech tools, but I really felt that I gained incredibly valuable experience by being present during the session.

I know that I speak on behalf of all the medical neuroscience students when I say that we are very grateful for the opportunity to be included in something like this.

See the article here:

Human brain dissected live in front of medical school students - The Argus

After 40 years in medicine, here’s what a Maine addiction expert has learned about alcohol, opioids and public health – Bangor Daily News

When The New York Times, the Washington Post and news agencies across Maine have needed to understand the opioid epidemic and the policies emerging in response to it, they have often turned to a specialist in addiction medicine working in Portland, Dr. Mark Publicker. Unafraid to criticize redundant task forces and barriers to treatment, his advocacy led to better policy and saved lives, said those who learned of his impending retirement online.

As the pandemic complicates the more hidden challenge of addiction, Publicker, 70, will retire from his private practice at the end of the year, after 40 years in medicine. He recently spoke about his career and the changing upheavals of the opioid crisis. Today, synthetic opioids, including fentanyl, are the most common drugs involved in drug overdose deaths in the United States.

While people in Maine may have heard of drug dealers mixing deadly fentanyl with heroin, the public may not know that dealers are also increasingly mixing fentanyl with cocaine and fentanyl with methamphetamine and that methamphetamine use is rising, said Publicker, who is the past president of the Northern New England Society of Addiction Medicine. Given fentanyls potency, the drug combinations may be contributing to Maines increasing number of overdoses.

Indeed, deaths involving cocaine and methamphetamine have increased in the past few years, according to state figures. The vast majority of those deaths have also involved opioids such as fentanyl.

It complicates the crisis, Publicker said. It also makes expanding access to treatment and educating medical providers about addiction as important as its ever been, said Publicker, who is also a fellow of the American Society of Addiction Medicine and a diplomate of the American Board of Addiction Medicine.

The following is a transcript of a telephone interview with Publicker, of Gorham, on Monday, Oct. 5, which has been edited for length and clarity.

Erin Rhoda, BDN: I remember being in a community meeting several years ago. Someone had a question relating to addiction treatment, and someone else spoke up and said, Well, Maine has a top expert in that. Talk to Dr. Mark Publicker. How did you come to be an expert in addiction medicine?

Mark Publicker: I started my career as a family physician in a nonprofit HMO in Pittsburgh. It was in a community of steelworkers, and they had a whole range of medical signs and symptoms. They had evidence of liver disease. They had blood pressure that was hard to control, gout. And my thinking was it was evidence of industrial poisoning that nobody else had identified. I was quite excited by this. And somebody loaned me a book about alcoholism in doctors. I woke up after reading it, slapped my forehead and said, Oh my God, half my patients are alcoholic. Now what do I do? It just so happened the doctor who wrote the book was one of the countrys first addiction psychiatrists, and he was practicing in Pittsburgh. So I went to see him.

He told me I should go to [Alcoholics Anonymous] meetings, which was hard for me being a non-alcoholic doctor. I went, and I started to recognize and understand more about alcoholism. I started to talk with my patients about my concerns and encourage them to go to meetings themselves, and initially I would go to meetings with them, which is something I wouldnt recommend doctors to do now. About six months later I started to get God bless you letters from patients and their families. I went, Wow, diabetics never sent you God bless you letters.

That was that. I began to study, got involved in the countrys foremost addiction medicine society, developed an addiction treatment program for this HMO, got certified in addiction medicine and was recruited from Pittsburgh to Washington, D.C., to develop Kaiser Permanentes addiction treatment program. I was there for 10 years. Mercy Hospital recruited me here.

Even though Im in Portland, the vast majority of my patients are from midcoast or Down East, and I can name every single little town on the midcoast where I have a patient coming from. I have got some people coming as far away as Machias. Theyre lobstermen, and theyre oystermen, and theyre blood wormers, clammers. And then land-based patients, roof and carpentry.

My patients recovery just belies with what peoples beliefs are about people with addictive histories. These guys go out in the middle of the Gulf in January to fish. If the lobsters arent there, theyre roofing. And if theyre not roofing, theyre doing carpentry. If theyre not doing carpentry, theyre doing hardscaping.

Weve [my wife and I] lived in a lot of places we figure 10 places in our marriage. Ive never seen a work ethic like this. I have these frankly wonderful patients, and its hard now for me to be starting this process of saying goodbye to them.

ER: As a doctor at a family medicine practice in Pittsburgh in the 1980s, how did addiction manifest itself then compared with today?

MP: What happened in Pittsburgh is instructive because the steel industry collapsed, and, along with that, communities collapsed, and drugs came in. When communities and cultures are wounded, drugs are more likely to come in.

What weve seen is a trend from primarily alcohol dependence in the country, to cocaine and prescription opiates, followed by intravenous heroin, supplanted by intravenous fentanyl.

Now the scary thing that were facing is increases in combinations of fentanyl with cocaine, and fentanyl with methamphetamine. What the cartels are doing is combining fentanyl with cocaine. People may not be aware that theyre using fentanyl, which may be one of the reasons that can account for the increase in overdose death rate over the last year or so.

In this state weve been largely spared methamphetamine. But no longer. Over the last year and a half its flooded into the state. The drug problem is quite severe and not showing any signs of slowing. In the midst of all of this, hidden, is high rates of alcohol dependence. Attention to it has been orphaned by the prescription opiate epidemic. It definitely kills more people per year than opiates do.

ER: I hadnt heard about the increased mix of fentanyl and methamphetamine.

MP: Its interesting because at noontime today we just had a presentation that was given by Millennium labs, which is one of these reference labs. The September 18 issue of JAMA [the Journal of the American Medical Association] published the results of their surveys of their lab results, from not only Maine but across the country. What theyre showing are like 300 percent increases and 400 percent increases in drug screens positive for fentanyl plus methamphetamine or fentanyl plus cocaine.

The study that was done compared pre-COVID and post-COVID. So post COVID is when these rates of co-occurring drug use have exploded. Its likely stress, unemployment, the circumstances that tend to increase drug use.

ER: When you first started treating people for their alcohol use disorder, it sounds like you werent formally taught how to talk to and treat people with alcoholism, and later sought out training yourself.

MP: To this day there is little to no formal education of medical personnel on addiction. Its rare to find any real coursework in medical school. Residencies have very little, and medical schools have been resistant to introducing significant curriculum to address the deficits. If you think about what are the major causes of preventable morbidity and mortality, theyre addictions. Its anything from nicotine to alcohol to opiates and benzos.

The most interesting thing Im doing these days is participating in this project with the Lunder-Dineen foundation. [It] is an alliance to teach Maine health professionals on a variety of topics, everything from dental health to care for the elderly. Theyd approached me about six years ago, asking me for a suggestion for a project for addiction. My proposal was to help teach medical professionals how to initiate and have conversations with their patients about their concerns about their drinking.

Its not simply a matter of writing a prescription. How do we talk with people? If you have a concern about your patients alcohol, how do you approach that? This is a major project with project managers from Mass General. Its a five-year project. Its being piloted now in seven health centers, federally qualified centers around the state. This is all in Maine.

ER: Tell me more about how you learned to respond to people and how your initial experiences affected how you later developed addiction treatment programs.

MP: The first thing I learned is that treating people with care and respect allows patients to not respond defensively but at least to allow you to have a conversation to express your concerns. Contrary to my fear initially that if I spoke with patients about my concerns they would become angry, instead [what I found is] they might not agree, but I was able to continue expressing my concerns and, over time, get people to change.

There are a number of behavioral tools that are extremely effective in helping people become motivated to change. Not just change addictions, but it could change almost any behavior. I wish I had thought about using it with my teenagers when they were in school. Its called motivational interviewing. The principles are expressing empathy, not arguing, avoiding confrontation, emphasizing self-efficacy.

This was contrary to the old concept of treating addictions by confronting people and causing them to feel debased in order to build up their new selves. This was a revolutionary concept. It was one of the things that I did training and ultimately taught, was the use of this technique called motivational interviewing, which is now I think regarded as central to treatment.

ER: Mercy Hospital in Portland recruited you to be the medical director of the hospitals recovery center in 2003, and you helped develop a maternal addiction program there. Youve called it perhaps the most rewarding thing in your career. What was the work like?

MP: We recognized that we were seeing a lot of pregnant women coming into our detox unit. This is opiates. We kind of asked ourselves, Well, what are we doing? We have all these pregnant women. We need to come up with some formal way to treat them. So a number of us got together. Twenty-four hours a day, if a woman came into the recovery center, we would admit them to our inpatient unit, assess them, give them treatment options, generally begin them on buprenorphine [a medication used to treat opioid use disorder].

[Then wed] discharge, transition them into our partial hospital program, which was six hours a day, five days a week; then move them into our intensive outpatient treatment program, which was three hours a day, five days a week; then ultimately into a group we called the Moms Group that met for an hour-and-a-half every week with a counselor and a nurse, with participation of one of the three addiction doctors at the recovery center.

We would encourage women to continue in the group after they gave birth, so we had mothers breastfeeding, and we had babies crawling on the floor. We had peer support through that. It was wonderful.

My wife first started out by knitting baby outfits and then developed her own diaper bags that women still cherish. I still hear from them. Its very gratifying. I dont think I ever did anything that gave me as much professional satisfaction and pride as working at the moms program.

ER: Mercys recovery center closed in 2015 because it was losing money. How did you feel?

MP: Everyone who was working there was, I think, heartbroken. We were sad because we had a tremendous program. We understood why Mercy did it. Nonetheless it was a major loss. I would have worked there for the rest of my career. But along with it, our mothers program ended. I think we all wished that had continued.

At that point I was 65 and had always worked for nonprofit organizations, and suddenly I didnt have a job. I made the decision that I was going to go into private practice, which has been successful, but its not as gratifying as working with a group of people and a program.

ER: When you opened your own private practice in Portland, what did you learn about the needs of the state of Maine from your patients?

MP: Maybe 75 percent or more of my patients are uninsured. So even though MaineCare was expanded, Ive got a population of working people who dont have health insurance who make too little to qualify for the ACA [Affordable Care Act] and too much to qualify for MaineCare. Ive got a lot of patients who are uninsured, which severely limits their access to treatment.

Much of the treatment in the state is based on participation in outpatient treatment programs. There are patients who have been sober for years who dont need to be in group. For certain populations who are working people, a requirement that people participate in a group is a real impediment to access to care. If youre a lobsterman, and in order to get your prescription you have to show up at a group on a Thursday afternoon, for example, but your captains going out, youre not going to that group, and youre not going to get your prescription. That serves as a barrier.

ER: I was looking back through some of my emails. In 2016 you wrote to me, virtually everything that is being proposed or done is wrong in Maine when it came to combating the opioid epidemic. One thing that youve fought for is the recognition of the science that medication helps people with addiction. Have you seen progress on this front?

MP: This is a significant issue. Weve got this action plan for the state. If you read it, what youll see is its based on buprenorphine. That to me is a major error.

[Asked about it, Gordon Smith, the states director of opioid response, said the administration supports all types of medications. The state has increased the MaineCare reimbursement rate for methadone, for instance, he said, and is pursuing additional methadone clinics.]

ER: How do the other Food and Drug Administration-approved medications, methadone and Vivitrol, fill a gap that buprenorphine, commonly known by its brand name Suboxone, cant?

MP: Not everybody can manage a prescription medicine. Some people do better with greater structure. Adherence rates may be better for somebody on methadone.

What can happen and what often happens is, somebody continues to use opiates or is unable to stop while on buprenorphine, and theyre discharged. Theres no understanding that there are alternatives that you can offer to people other than simply to discharge them.

We know that methadone has been proven to be effective since the 60s. It should be part of our armamentarium. It also allows us to expand access to care. Vivitrol, which is an injectable form of the drug naltrexone, has also been shown to be very effective. All of the medications that are FDA approved should be part of our opiate response.

ER: As you know, the number of drug deaths rose in Maine as the pandemic shut everything down. What are your words of advice for what the state should do to slow the rate of death?

MP: It would be wonderful if I had the solution to this problem, which I dont. Let me start with that earned humility. No, I dont have an answer to this other than to recognize that our treatment programs may be so focused on opiates that we are forgetting that there are other drugs that may need to be addressed. Ill say this in regards to alcohol as a co-factor in deaths treatment isnt really available.

When I say to you, Gee, we have this tremendous increase in co-occurrence of fentanyl and methamphetamine, your answer is, I didnt know that. The knowledge that we have this problem isnt known yet, and that knowledge needs to be expanded. The fact that we have a methamphetamine epidemic is probably still not widely known. But we do. Cocaine is still prevalent.

The problem is more difficult, more complex and more resistant to solutions. I think we ought to try to solve what we can. Effective medication management is one such way, but that needs to be expanded to all medications.

If you look at the states action plan, education isnt part of it. In general, broader education of Maine health practitioners on addiction would improve our response to the epidemic. It should be included in our action plan.

[While we have not prioritized the education of future medical professionals on addiction, both medical schools have adopted new curriculum doing just that, said Smith, with the state. Plus, several family medicine residency programs are requiring all of their residents to get the needed approval to provide medication-assisted treatment, he said.]

ER: Maybe you could talk about why you decided to retire, and how you feel about it.

MP: Ive been debating this now for a year and a half. While there are a lot of rewards from private practice, it also has limited my ability to do things that I enjoy such as teaching and volunteering in the community.

Its time for me to figure out something else in addition to only practicing medicine for 40 years. Im not giving up medicine, but Im definitely moving to another stage in my life.

Go here to see the original:

After 40 years in medicine, here's what a Maine addiction expert has learned about alcohol, opioids and public health - Bangor Daily News

Trumps Lying Personal Physician And Dr. Umar Johnson Went To The Same Med School – News One

As if the situation surrounding Donald Trumps case of the coronavirus couldnt get any less predictable, it turns out that the presidents personal physician whos been under fire for telling apparent lies (go figure) graduated from the same medical school from which Dr. Umar Johnson earned his much-maligned doctorate.

That fact was an interesting twist to an already convoluted story centered onDr. Sean Conley, who has given the media conflicting reports about Trumps treatment (in other words, he lied) and has been accused of following the White Houses script to paint an optimistic picture of the presidents health that admittedly wasnt completely accurate.

While the fact that Conley and Umar Johnson both graduated from the Philadelphia College of Osteopathic Medicine is one tie that binds the two, the doctor of osteopathic medicine (D.O.) and his weekend of lying bore similarities to his doctor of clinical psychology counterpart, who has also been accused of telling lies albeit their lies having different degrees of urgency. (Yes, thats right, the presidents physician is not an M.D., or medical doctor.)

Conley admitted Sunday to lying a day before when he downplayed Trumps health prognosis to reflect the upbeat attitude that the team, the president, that his course of illness has had. Conley explained to reporters that he lied because he didnt want to give any information that might steer the course of illness in another direction.

Johnson, for is part, never really lied, per se, as much as just flat-out misrepresented himself as a doctor for years before earning his PhD in 2012. However, hes been accused of lying about raising money to purportedly build a school for Black boys. Hes reportedly helped raise hundreds of thousands of dollars (other rumors say as much as $1 million) in donations forthe construction of a schoolthat he seemingly never intended to build. For the record, he has insisted otherwise, as shown during the epic episode of NewsOne Now with Roland Martin from two summers ago.

Black Enterprise reported in 2014that Johnson launched an initiative to fund an all-Black boys school. At the time, Johnson said he was gaming to raise $5 million to buy St. Pauls College, an HBCU in Lawrenceville, Virginia, and convert it into a boarding school for young African American boys.

Five years later, Johnson announced in a video that he had finally raised the funds to buy property in Wilmington, Delaware, to house the Frederick Douglas Marcus Garvey Academy (FDMG).

However, Johnson said in a Labor Day video that he still needed money for the renovation of FDMG Academy. He said he already has the architectural plan but still needs money to pay for the electrician and HVAC and the fire alarm and the sprinkler company.

Conley, for his part, came under scrutiny in May for treating Trump with the drug hydroxychloroquine purportedly as a preventive measure against contracting the coronavirus despite medical studies suggesting the anti-malaria medication could be fatal and futile against Covid-19.

Still, Conley said at the time, he and Trump concluded the potential benefit from treatment outweighed the relative risks.

Five months later Trump is battling the coronavirus without any true indication of how severe it is both are no thanks to Conley and Johnsons school for Black boys remains unbuilt.

SEE ALSO:

Trump Has The Coronavirus: What His Pre-Existing Health Conditions Mean In The Long, Or Short, Run

Trump Planned To Use Black Woman As A Prop During Debate Before Racist Meltdown

More:

Trumps Lying Personal Physician And Dr. Umar Johnson Went To The Same Med School - News One

Study Finds Older Adults Using Cannabis to Treat Common Health Conditions – UC San Diego Health

With growing interest in its potential health benefits and new legislation favoring legalization in more states, cannabis use is becoming more common among older adults.

University of California San Diego School of Medicine researchers report that older adults use cannabis primarily for medical purposes to treat a variety of common health conditions, including pain, sleep disturbances and psychiatric conditions like anxiety and depression.

The study, published online October 7, 2020 in the Journal of the American Geriatrics Society, found that of 568 patients surveyed, 15 percent had used cannabis within the past three years, with half of users reporting using it regularly and mostly for medical purposes.

Pain, insomnia and anxiety were the most common reasons for cannabis use and, for the most part, patients reported that cannabis was helping to address these issues, especially with insomnia and pain, said Christopher Kaufmann, PhD, co-first author of the study and assistant professor in the Division of Geriatrics and Gerontology in the Department of Medicine at UC San Diego.

Patients surveyed in the study were seen at the Medicine for Seniors Clinic at UC San Diego Health over a period of 10 weeks.

The researchers also found that 61 percent of the patients who used cannabis had initiated use after age 60.

Surprisingly, we found that nearly three-fifths of cannabis users reported using cannabis for the first time as older adults. These individuals were a unique group compared to those who used cannabis in the past, said Kevin Yang, co-first author and third-year medical student at UC San Diego.

New users were more likely to use cannabis for medical reasons than for recreation. The route of cannabis use also differed with new users more likely to use it topically as a lotion rather than by smoking or ingesting as edibles. Also, they were more likely to inform their doctor about their cannabis use, which reflects that cannabis use is no longer as stigmatized as it was previously.

Given the rise in availability of CBD-only products, which is a non-psychoactive cannabinoid in contrast to THC-containing products, the researchers said it is likely that future surveys will continue to document a larger proportion of older adults using cannabis or cannabis-based products for the first time.

Alison Moore, MD, chief of the Division of Geriatrics in the Department of Medicine at UC San Diego School of Medicine.

The findings demonstrate the need for the clinical workforce to become aware of cannabis use by seniors and to gain awareness of both the benefits and risks of cannabis use in their patient population, said Alison Moore, MD, senior author and chief of the Division of Geriatrics in the Department of Medicine at UC San Diego School of Medicine. Given the prevalence of use, it may be important to incorporate evidence-backed information about cannabis use into medical school and use screening questions about cannabis as a regular part of clinic visits.

The researchers said future studies are imperative to better understanding the efficacy and safety of different formulations of cannabis in treating common conditions in older adults, both to maximize benefit and minimize harm.

There seems to be potential with cannabis, but we need more evidence-based research. We want to find out how cannabis compares to current medications available. Could cannabis be a safer alternative to treatments, such as opioids and benzodiazepines? Could cannabis help reduce the simultaneous use of multiple medications in older persons? We want to find out which conditions cannabis is most effective in treating. Only then can we better counsel older adults on cannabis use, said Kaufmann.

Geriatrics at UC San Diego Health was recently ranked thirteenth in the nation in the 2020-2021 U.S. News & World Report survey. The geriatrics and gerontology team at UC San Diego Health is committed to providing top quality, evidence-based care to older adults.

Co-authors of the study include: Reva Nafsu, Ella Lifset, Khai Nguyen and Michelle Sexton, all at UC San Diego; and Benjamin Han and Arum Kim, New York University School of Medicine.

Funding for this study came, in part, from the National Institutes of Health (T35AG26757, K01AG061239, P30AG059299, K23DA043651), the Stein Institute for Research on Aging, the Center for Healthy Aging and the Division of Geriatrics and Gerontology at UC San Diego.

Go here to read the rest:

Study Finds Older Adults Using Cannabis to Treat Common Health Conditions - UC San Diego Health

U of M Medical School Researchers Found Traces Of COVID-19 On Beaches – FOX 21 Online

DULUTH, Minn. Researchers at the University of Minnesota Medical School Duluth are reporting they have found traces of the COVID-19 virus in water from four area beaches.

The group has been taking samples from eight local beaches since July.

Researchers have found evidence of the genetic makeup of the COVID-19 virus at Leif Erikson, Park Point, Brighton, and 42nd Avenue beaches between the weekend of September 11th and 18th.

It is still unclear where the source or sources are coming from, but experts say testing samples might help answers some unresolved questions about COVID-19 in the area.

By watching for its presence may be able to show how long it stays or if it goes away. It will help understanding lake processes and levels of infection, said Dr. Richard Melvin, assistant professor of Biomedical Sciences. All of those things will help us find out how the virus ends up in the water.

U of M Medical School researchers will be continuing to monitor and take samples from all beaches for the next four to eight weeks.

Go here to read the rest:

U of M Medical School Researchers Found Traces Of COVID-19 On Beaches - FOX 21 Online